You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • AB0444 Assessment of Structural Benefits of SC Abatacept Using MRI in Patients with RA Who Have Failed 1 or 2 TNFS and Correlated with Clinical Outcomes as Measured by DAS28(ESR)

Citation Tools

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Rheumatoid arthritis - other biologic treatment
AB0444 Assessment of Structural Benefits of SC Abatacept Using MRI in Patients with RA Who Have Failed 1 or 2 TNFS and Correlated with Clinical Outcomes as Measured by DAS28(ESR)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gaylis N, Needell S, Sagliani J
AB0444 Assessment of Structural Benefits of SC Abatacept Using MRI in Patients with RA Who Have Failed 1 or 2 TNFS and Correlated with Clinical Outcomes as Measured by DAS28(ESR)
Annals of the Rheumatic Diseases 2014;73:955.